Aspirin for the Prevention of Cardiovascular Events in the Elderly

By Mahé I.  

Drugs & Aging, Vol. 20, Iss. 13, 2003-01 ,pp. : 999-1010

Adis International

Access to resources Recommend Favorite

Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly: Aspirin in Reducing Events in the Elderly (ASPREE)

By Nelson M.R.   Reid C.M.  

Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. : 897-903

Adis International

Access to resources Recommend Favorite

Aspirin Use for the Primary Prevention of Cardiovascular Disease in the Elderly

By Sarbacker G. Blair   Lusk Kathleen A.   Flieller Lauren A.   Van Liew Jeffrey R.  

The Consultant Pharmacist, Vol. 31, Iss. 1, 2016-01 ,pp. : 24-32

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Weigh risks and benefits of aspirin in the secondary or primary prevention of cardiovascular events in elderly individuals

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 8, 2004-08 ,pp. : 8-11

Adis International

Access to resources Recommend Favorite

Contrast Agents for Cardiovascular Magnetic Resonance Imaging: Current Status and Future Directions

By Schalla S.   Higgins C.B.   Saeed M.  

Drugs in R&D, Vol. 3, Iss. 5, 2002-01 ,pp. : 285-302

Adis International

Access to resources Recommend Favorite